Latest in Cardiology from ACC.org

• State-of-the-Art Review Outlines Multidisciplinary Framework For Cardiogenic Shock Survivorship
  With survival rates after cardiogenic shock (CS) increasing, a JACC State-of-the-Art Review outlines a multidisciplinary, longitudinal approach to CS care aimed at "providing a clinically actionable structure for care pathways, resource planning and future research."
• Joint Clinical Consensus Statement Focuses on Masters Athletes With Abnormal CV Findings
  Masters athletes, defined as adults over the age of 35 years, with more than 300 minutes per week of exercise training, are driven by performance goals in addition to health goals. For those with abnormal CV findings, diagnostic assessment, treatment options, and exercise prescriptions or restrictions have limited generalizability...
• JACC Spotlight Issue Highlights New 2026 Acute PE Guideline
  A new Spotlight Issue of JACC centers on the Guideline For the Evaluation and Management of Acute Pulmonary Embolism in Adults, released by the ACC and AHA earlier this year.
• Eagle’s Eye View: Top Takeaways from ACC.26
  In this week’s View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30.
• HOST-EXAM: Clopidogrel vs. Aspirin Monotherapy at 10 Years Post PCI
  Clopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet.